15 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

COLONGLIDE(R) LUBRICANT

FDA 510(k)
FDA Class 1 ·General Hospital

SURGISTAR, INC.

FDA UDI
SURGISTAR, INC.·00878799002556·

CARDINAL HEALTH

FDA UDI
Cardinal Health 200, LLC·10887488229843·ULTRASOUND NERVE BLOCK PREP

FLEXITIME XTREME 2 HEAVY TRAY CARTRIDGE REFILL, FEXITIME XTREME 2 LIGHT TRAY CARTRIDGE REFILL

FDA 510(k)
FDA Class 2 ·Dental

MEDIPLUS SINGLE USE LOWER GI MANOMETRY CATHETER

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523151592·Tesera-k SA, 31mm X 26mm X 17mm, 12° Lordosis, T3

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523157266·Tesera-k ALIF, 31W X 26D, 17mm, 12° Broach

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523156511·Tesera-k ALIF, 31W X 26D, 17mm, 12° Trial

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·April 15, 2026

MECTALIF TRANSFORAMINAL INTERBODY FUSION DEVICE 12X30X8 L°

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code MAX·September 14, 2018

PORTABLE OXYGEN GENERATOR (CONCENTRATOR, HOMEFILL)

FDA Adverse Event
Malfunction ·INVACARE FLORIDA OPERATIONS·Product code CAW·October 1, 2014

HEARTSTART MRX

FDA Adverse Event
Malfunction ·PHILIPS MEDICAL SYSTEMS·Product code MKJ·May 17, 2013

CONCERTO II CRT-D

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL, INC.·Product code NIK·June 16, 2011

Eversense CGM SENSOR (FG-4200-00-301)-Continuous Glucose Monitor

FDA Enforcement
Class II ·Terminated·Senseonics, Inc.·November 6, 2019

Ultraview SL Command Modules, Model 91496, with the Masimo SpO2 PCBA, PN: 010-1636-02. The Spacelabs Multi-parameter Module is intended for use with the Patient Care Management System (PCMS) to acquire, monitor, and process various clinical parameters from an adult or neonate/infant populations in any type of clinical environment other than home use.

FDA Enforcement
Class II ·Terminated·Spacelabs Healthcare Inc·May 13, 2015